Anafylaksi hos børn og voksne

Kirsten Skamstrup, Lene Heise Garvey, Carsten Bindslev-Jensen, Susanne Halken, Marianne Sjølin Frederiksen, Torsten Lauritsen, Thomas Houmann Petersen, Johannes Schmid, Sandra Viggers, Hans-Jørgen Malling

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

In this review, we discuss anaphylaxis, which is a severe allergic condition with potentially life-threatening symptoms from airways or circulation and often associated with skin symptoms. First-line treatment is intramuscular adrenaline given by autoinjector for rapid administration. Initial dose for children < 25 kg is 0.15 mg and for children ≥ 25 kg and adults 0.3 mg. Repeated smaller doses of adrenaline is to be preferred. Patients with severe anaphylaxis will need an IV access for fluid replacement and supplementary oxygen. Antihistamines and steroids are only second-line treatment after adrenaline administration.
Bidragets oversatte titelAnaphylaxis in children and adults
OriginalsprogDansk
ArtikelnummerV07200537
TidsskriftUgeskrift for Laeger
Vol/bind183
Udgave nummer7
ISSN0041-5782
StatusUdgivet - 2021

Fingeraftryk

Dyk ned i forskningsemnerne om 'Anafylaksi hos børn og voksne'. Sammen danner de et unikt fingeraftryk.

Citationsformater